Skip to main content
Premium Trial:

Request an Annual Quote

Pairings: Jul 27, 2011


Verinata Health has tapped Noah Nasser, Suzanne Yokota, and Xitong Li to develop its next-generation sequencing-based fetal diagnostic testing business.

Nasser, who formerly was a business unit manager for molecular diagnostics at Quidel, will be Verinata's vice president of sales and market development. Yokota, who will be Verinata's new VP of marketing and commercial operations, started with the company last year and formerly was commercial director at Satoris, prior to which she held several management posts at Affymetrix. Li, who will be Verinata's director of bioinformatics, was associate director of bioinformatics at Genomic Health, and worked previously at Ingenuity Systems and Novartis.

Lophius Biosciences has hired Karl Kleine as head of quality management and Kornelia Schlombs to serve as scientific project manager for molecular biology.

Kleine formerly was involved in quality management at Cogenics, and before that he worked at Epidauros Biotechnologies. Schlombs previously was in charge of genotyping studies at Epidauros.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.